Concepedia

Aurélie Terrier

AT

Statistics

Publications

5

Citations

139

H-Index

5

Active since

2015

Affiliations

LFB (France)(Current)

Inserm

Aurélie Terrier is an author at LFB (France) specializing in molecular biology, biochemistry, and antibody engineering.

Publications per year

2015–2021

5

Publications

5

Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies

Mathilde Bas, Aurélie Terrier, Émilie Jacque et al. · The Journal of Immunology · 2019 · 82 citations

Life Sciences, Biochemistry, Molecular Biology +17

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells

Pauline Estupina, Alexandre Fontayne, Jean‐Marc Barret et al. · Oncotarget · 2017 · 20 citations · Full text

Medicine, Immunology, Oncology +16

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies

Céline Monnet, Émilie Jacque, Christophe de Romeuf et al. · Frontiers in Immunology · 2021 · 15 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Characterization of monoclonal antibodies by a fast and easy liquid chromatography–mass spectrometry time-of-flight analysis on culture supernatant

Antoine Henninot, Aurélie Terrier, Julie Charton et al. · Analytical Biochemistry · 2015 · 12 citations

Pharmacy, Biochemistry, Molecular Biology +14

Improved<i>in vitro</i>and<i>in vivo</i>activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern

Nathalie Fournier, Émilie Jacque, Alexandre Fontayne et al. · mAbs · 2018 · 10 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 5